FDA NDC Directory · JSON-LD · Markdown

LEXISCAN

NDC 0469-6501 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameregadenoson
Labeler / ManufacturerAstellas Pharma US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022161
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON (.08 mg/mL)
Marketing started20080410
Package count1

External sources

Source: openFDA. Public-domain (CC0).